
Chenghao Zhu
@chenghao_zhu


T Cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) +/- Pembrolizumab (KEYNOTE-603). Cancer Discovery. 🚨OncoAlert 🏥 Phase I, resected #NSCLC & #melanoma 💊No grade 4/5 AEs ✅Neoantigen-specific T cell responses and expansion after combo doi.org/10.1158/2159-8…


checkout our latest paper in Nature Biotechnology. We developed a graph-based algorithm that comprehensively generates non-canonical peptides in linear time. nature.com/articles/s4158…


David Geffen School of Medicine at UCLA UCLA Health UCLA Jonsson Comprehensive Cancer Center Temerty Medicine Princess Margaret Cancer Centre Research Vector Institute Boutros Lab Thomas Kislinger Chenghao Zhu Proteogenomics algorithm improves the detection of hidden genetic mutations #NBTIntheNews via Genetic Engineering & Biotechnology News genengnews.com/topics/artific…

The algorithm unlocks the full potential of proteogenomics by overcoming a key challenge in linking genetic mutations to protein-level changes. David Geffen School of Medicine at UCLA UCLA Jonsson Comprehensive Cancer Center newsroom.ucla.edu/stories/new-co…
